These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 210375

  • 1. [Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)].
    Mertz DP, Suermann I, Göhmann E.
    MMW Munch Med Wochenschr; 1978 Aug 25; 120(34):1097-9. PubMed ID: 210375
    [Abstract] [Full Text] [Related]

  • 2. [Influence of "prudent" diet and clofibrate upon apolipoprotein B in hyperlipoproteinemia type IIa (author's transl)].
    Mertz DP, Suermann I, Göhmann E.
    Med Klin; 1979 Feb 23; 74(8):279-83. PubMed ID: 216895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Feb 23; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The detection of apolipoproteins AI and B in the liver of patients with and without hyperlipoproteinemia (author's transl)].
    Hopf U, Schwartzkopff W, Assmann G, Beger HG, Ramadori G, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1981 Jun 23; 19(6):284-92. PubMed ID: 6789566
    [Abstract] [Full Text] [Related]

  • 15. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W, Kremer GJ, Müller D.
    MMW Munch Med Wochenschr; 1975 Oct 31; 117(44):1783-6. PubMed ID: 171564
    [Abstract] [Full Text] [Related]

  • 16. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J, Mühlfellner G, Mühlfellner O, Hausmann L, Schubotz R.
    Arzneimittelforschung; 1980 Oct 31; 30(11b):2059-62. PubMed ID: 7194060
    [Abstract] [Full Text] [Related]

  • 17. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L, Olsson AG, Rössner S, Carlson LA.
    Postgrad Med J; 1975 Oct 31; 51(8):suppl 76-81. PubMed ID: 215986
    [Abstract] [Full Text] [Related]

  • 18. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J, Sauvanet JP, Chanu B, Bakir R, Goy-Loeper J, Saya C, Pinaroli F.
    Nouv Presse Med; 1980 Dec 22; 9(49):3747-51. PubMed ID: 7208341
    [Abstract] [Full Text] [Related]

  • 19. [Chances in the serum lipid values after conversion to a "reasonable" diet (author's transl)].
    Mertz DP, Wobbe HD, Berger A, Göhmann E.
    Med Klin; 1977 Jan 14; 72(2):47-54. PubMed ID: 189169
    [Abstract] [Full Text] [Related]

  • 20. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].
    Sznajd J, Idzior-Waluś B, Korzus G, Zabiński J, Hebda A, Markiewicz M.
    Przegl Lek; 1990 Jan 14; 47(10):711-4. PubMed ID: 2089450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.